医学
抗磷脂综合征
羟基氯喹
怀孕
血栓形成
阿司匹林
疾病
肝素
发病机制
重症监护医学
免疫学
产科
内科学
生物
传染病(医学专业)
遗传学
2019年冠状病毒病(COVID-19)
作者
Kayoko Kaneko,Nobuaki Ozawa,Atsuko Murashima
标识
DOI:10.1080/25785826.2021.1969116
摘要
Antiphospholipid syndrome (APS) is an autoimmune disease characterized by clinical manifestations such as thrombosis and obstetric complications with documented persistence of antiphospholipid antibodies (aPLs). Recent studies have revealed that the cause of aPL-related obstetric complications is dysfunction of placental trophoblasts and inflammation of the maternal-fetal interface induced by aPLs, not thrombosis. Although aPLs are associated with recurrence of serious complications during pregnancy, appropriate combination therapy with heparin and low-dose aspirin can improve the course of 70-80% of subsequent pregnancies. Preconception counseling and patient-tailored treatment are fundamental to improving maternal and fetal outcomes. Non-anticoagulant treatments such as hydroxychloroquine and statins are being developed for cases refractory to conventional treatment. Risk factors for thrombosis after pregnancy complications were identified based on the analysis of large databases of obstetric APS.
科研通智能强力驱动
Strongly Powered by AbleSci AI